Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zulresso in Perimenopausal Depression
NCT05329779Phase 4Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
A Phase 4 trial of brexanolone in major depressive disorder (MDD), sponsored by Brigham and Women's Hospital. Started Nov 2022; status: terminated.
02
Drugs
brexanolone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05329779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05329779.